Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.
Worldwide our employees work together to deliver cutting edge generics solutions that help to keep our customers ahead of the competition.
Headquartered in Rotterdam (Netherlands), we have manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico.
The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals